PokeAcell’s mission is to provide curative treatment to solid tumor patients with no available treatment options. We combine a deep immunological understanding with state-of-the-art technology to create a better future for patients.
PokeAcell is based on the distinct expertise of our CSO Prof. Sine R. Hadrup, Ph.D., and her highly recognized scientific work within tumor antigen mapping and T cell detection. With our experienced founder team and world-leading advisors, PokeAcell aims to provide curative treatment to solid tumor patients with leadership in innovative T cell therapies.